{"title":"化疗药物靶向递送的改进","authors":"Rasha R Radwan","doi":"10.21767/2321-547X.1000001","DOIUrl":null,"url":null,"abstract":"Drug delivery systems offer the potential to improve the therapeutic index of chemotherapeutic agents via targeting the antitumor drug to its desired site of action, and hence, increasing the drug concentration in cancer cells and decreasing its concentration in healthy cells. Several nano-sized drug carriers, such as nanoparticles, liposomes, micells and polymer-drug conjugates, have been investigated in order to minimize side effects of anticancer drugs and enhance the antitumoral drug efficacy in cancer therapy.","PeriodicalId":7704,"journal":{"name":"American Journal of Advanced Drug Delivery","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improved Targeted Delivery for Chemotherapeutic Drugs\",\"authors\":\"Rasha R Radwan\",\"doi\":\"10.21767/2321-547X.1000001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drug delivery systems offer the potential to improve the therapeutic index of chemotherapeutic agents via targeting the antitumor drug to its desired site of action, and hence, increasing the drug concentration in cancer cells and decreasing its concentration in healthy cells. Several nano-sized drug carriers, such as nanoparticles, liposomes, micells and polymer-drug conjugates, have been investigated in order to minimize side effects of anticancer drugs and enhance the antitumoral drug efficacy in cancer therapy.\",\"PeriodicalId\":7704,\"journal\":{\"name\":\"American Journal of Advanced Drug Delivery\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Advanced Drug Delivery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21767/2321-547X.1000001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Advanced Drug Delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21767/2321-547X.1000001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Improved Targeted Delivery for Chemotherapeutic Drugs
Drug delivery systems offer the potential to improve the therapeutic index of chemotherapeutic agents via targeting the antitumor drug to its desired site of action, and hence, increasing the drug concentration in cancer cells and decreasing its concentration in healthy cells. Several nano-sized drug carriers, such as nanoparticles, liposomes, micells and polymer-drug conjugates, have been investigated in order to minimize side effects of anticancer drugs and enhance the antitumoral drug efficacy in cancer therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
